Constitutively ctive FOXO1a and a DNA-binding domain mutant exhibit distinct co-regulatory functions to enhance progesterone receptor A activity

Journal of Molecular Endocrinology

Volumn 38, Issue 5-6, 2007, Pages 673-690

  Rudd, Michael D ^b   Gonzales Robayna, Ignacio ^a   Henandez Gonzalez, Inmaculada ^a   Weigel, Nancy L ^b   Bingman III, Wiliam E ^b   Richards, JoAnne S ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID; GLUTATHIONE TRANSFERASE; HORMONE RECEPTOR; LEUCINE; PROGESTERONE RECEPTOR A; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FOXO; FORKHEAD TRANSCRIPTION FACTOR; FOXO1A PROTEIN, RAT; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE MUTATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HORMONE RESPONSIVE ELEMENT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF; RAT; REGULATORY MECHANISM; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; COMPARATIVE STUDY; GENETICS; METABOLISM; MUTATION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; MUTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROGESTERONE;

EID: 34347384383     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0017     Document Type: Article

References (48)

1. Accili D & Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation and transformation. Cell 117 421-426.
2. Baron S, Escande A, Alberola G, Bystricky K, Balaguer P & Richard-Foy H 2007 Estrogen recetpor a and the AP1 complex coorperate during IGF-1-induced transcriptional activation of the pS2/TFF1 gene. Journal of Biological Chemistry 282 11732-11741.
3. Bennicelli JL, Fredericks WJ, Wilson RB, Rauscher FJI & Barr FG 1995 Wild-type PAX3 protein and PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11 119-130.
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ,Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME et al. 1999 Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96 857-868.
5. Brunet A, Park J, Tran H, Hu LS, Hemmings BA & Greenberg ME 2001 Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Molecular and Cellular Biology 21 952-965.
6. Burgering BM & Kops GJ 2002 Cell cycle and death control: long live Forkheads. Trends in Biochemical Science 27 352-360.
7. Castrillon DH, Miao L, Kollipara K, Horner JW & DePinho RA 2003 Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301 215-218.
8. Cunningham MA, Zhu Q & Hammond JM 2004 FoxO1a can alter cell cycle progression by regulating the nuclear localization of p27kip in granulosa cells. Molecular Endocrinology 18 1756-1767.
9. Doyle KMH, Russell DL, Sriraman V & Richards JS 2004 Coordinate transactivation of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Molecular Endocrinology 18 2463-2478.
10. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM & Korswagen HC 2005 Functional interaciton bewteen beta-catenin and FOXO in oxidative stress signaling. Science 308 1181-1184.
11. Fitzpatrick SL & Richards JS 1991 Regulation of cytochrome P450 aromatase messenger ribonucleic acid and activity by steroids and gonadotropins in rat granulosa cells. Endocrinology 129 1452-1462.
12. Furuyama I, Kitayama K, Shimoda Y, Ogawa M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S-i, Nakayama K, Nakayama K et al. 2004 Abnormal angiogenesis in Foxo1 (Fkhrt)-deficient mice. Journal of Biological Chemistry 279 34741-34749.
13. Gao J, Mazella J, Suwanichkul AM, Powell DR & Tseng L 1999 Activation of the insulin-like growth factor binding protein 1 promoter by progesterone receptor in decidualized human endometrial cells. Molecular and Cellular Endocrinology 153 11-17.
14. Gao J, Mazella J, Tang M & Tseng L 2000 Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the e xpression of the insulin-like growth factor binding protein-1 (IGFBP-1) in humman endometrial cells. Molecular Endocrinology 14 1954-1961.
15. Giangrande PH, Pollio G & McDonnell DP 1997 Mapping and characterization of the functional domains responsible for the differential activity of the A and B form of the human progesterone receptor. Journal of Biological Chemistry 272 32889-32900.
16. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL & Richards JS 2000 FSH stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A-kinase independent signaling in granulosa cells. Molecular Endocrinology 14 1283-1300.
17. Hang H, Muddiman DC & Tindall DJ 2004 Androgens negatively regualte forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. Journal of Biological Chemistry 279 13866-13877.
18. Heery DM, Hoare S, Hussain S, Parker MG & Sheppard H 2001 Core LXXLL motif sequences in CREB-binding protein SRC1 and RIP140 define affinity and selectivity for steroid and retinoid receptors. Journal of Biological Chemistry 276 6695-6702.
19. Van der Heide LP & Smidt MP 2005 Regulation of FoxO activity by CBP/ P300-mediated acetylation. Trends in Biochemical Science 30 81-86.
20. Van der Heide LP, Hoekman MF & Smidt MP 2005 The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcsiptional regulation. Biochemical Journal 380 297-309.
21. Hirota K, Daitoku H, Matsuzaki H, Araya N, Yamagata K, Asada S, Sugaya T & Fukamizu A 2003 Hepatocyte nuclear factor 4 is a novel downstream target of insulin via FKHR as a signal-regulated transcriptional inhibitor. Journal of Biological Chemistry 278 13056-13060.
22. Hosaka T, Biggs WH, Tieu D, Boyer AD, Varki NM, Cavenee WK & Arden KC 2004 Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. PNAS 101 2975-2980.
23. Kenyon C 2005 The plasticity of aging: insights from long-lived mutants. Cell 120 449-480.
24. Kim JJ, Buzzio OL, Li S & Lu Z 2005 Role of FOXO1A in the regulation of insulin-like growth factor binding protein-1 in human endometrial cells; interaction with progesterone receptor. Biology of Reproduction 73 833-839.
25. Kodama S, Koike C, Negishi M & Yamamoto Y 2004 Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Molecular and Cellular Biology 24 7931-7940.
26. Kops GJPL, De Ruiter ND, De Vries-Smits AMM, Powell DR, Bos JL & Burgering BMTh 1999 Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398 630-634.
27. Kops GJPL, Medema RH, Glassford J, Essers MAG, Dijkers PF, Coffer PJ, Lam EW-F & Burgering BMT 2002 Control of cell cycle exit and entry by protein kinase B-regualted forkhead transcription factors. Molecular and Cellular Biology 22 2025-2036.
28. Li P, Lee H, Guo S, Unterman TG, Jenster G & Bai W 2003 AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR. Molecular and Cellular Biology 23 104-118.
29. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 465-474.
30. KIP1. Nature 404 782-787.
31. Nakae J, Kitamura T, Ogawa W, Kasuga M & Accili D 2001 Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. Biochemistry 40 11768-11776.
32. Park Y, Maizels ET, Feiger ZJ, Alam H, Peters CA, Woodruff TK, Unterman TG, Lee EJ, Jameson JL, Hunzicker-Dunn M el al. 2005 Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad. Journal of Biological Chemistry 280 9135-9148.
33. Potente M, Urbich C, Sasaki K-i, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM & Dimmeler S 2005 Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. Journal of Clinical Investigation 115 2382-2392.
34. Powse DM, Bolgan L, Molnar L & Dotto GP 1997 Involvement of the Sp3 transcription factor in induction of p21CIP1/KIP1 in keratinocyte differentiation. Journal of Biological Chemistry 272 1308-1314.
35. Puigserver P, Wu Z, Park CW, Graves R, Wright M & Speigelman BM 1998 A cold-inducible coactivator of nuclear receptors linke to adaptive thermogenesis. Cell 92 829-839.
36. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Doug H, Accili D et al. 2003 Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC1 alpha interactions. Nature 423 550-555.
37. Ramaswamy S, Nakamura N, Sansal I, Bergeron L & Sellers WR 2002 A novel mechanism of gene regulation and tumor suppression by transcription factor FKHR. Cancer Cell 2 81-91.
38. Richards JS, Ochsner S, Russell DL, Falender AE, Hsieh MN, Doyle RH & Sharma SC 2002a Novel signaling pathways that control follicular growth and ovulation. Recent Progress in Hormone Research 57 57195-57220.
39. Richards JS, Sharma SC, Falender AE & Lo YH 2002b Expression of FKHR, FKHRL1 and AFX genes in the rodent ovary: evidence for regulation by IGF-1, estrogen and the gonadotropins. Molecular Endocrinology 17 520-533.
40. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Molecular Endocrinology 15 209-218.
41. Schuur ER, Loktev AV, Sharma M, Sun Z, Roth RA & Weigel RJ 2001 Ligand-dependent interaction of estrogen receptor-a with FKHR. Journal of Biological Chemistry 276 33554-33560.
42. Seoane J, Le H-V, Shen L, Anderson SA & Massague J 2004 Integration of Smad and Forkhead pathways iin the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 211-223.
43. Shi F & LaPolt PS 2003 Relationship between FoxO1 protein levels and follicular development, atresia, and luteinization in the rat ovary. Journal of Endocrinology 179 195-203.
44. Sriraman V, Sharma SC & Richards JS 2003 Transactivation of the progesterone receptor gene in granulosa cells: evidence that Sp1/Sp3 binding sites in the proximal promoter play a key role in luteinizing hormone inducibility. Molecular Endocrinology 17 436-449.
45. Sriraman V, Lohmann S, Molders S & Richards JS 2005 Cyclic guanosine 5′-monophosphate-dependent protein kinase II is induced by luteinizing hormone and progesterone receptor-dependent mechanisms in granulosa cells and cumulus oocyte complexes of ovulating follicles. Molecular Endocrinology 20 348-361.
46. Takimoto GS, Tung L, Abdel-Hafiz H, Abel MG, Sartorious CA, Richer JK, Jacobsen BM, Bain DL & Horwitz KB 2003 Functional properties of the N-terminal region of the progesterone receptors and their mechanistic relationship to structure. Journal of Steroid Biochemistry and Molecular Biology 85 209-219.
47. Tang ED, Nunez G, Barr FG & Guan KL 1999 Negative regulation of the forkhead transcription factor FKHR by Akt. Journal of Biological Chemistry 274 16741-16746.
48. Zhao HH, Herrera RF, Coronado-Heinsohn E, Yang MC, Ludes-Meyers JH, Seybold-Tilson KJ, Nawaz Z, Yee D, Barr FG, Diab SG et al. 2001 Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear hormone receptor-interacting protein with coactivator and corepressor functions. Journal of Biological Chemistry 276 27907-27912.